Skip to content

The Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men

The Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05264233
Acronym
CocoHeart
Enrollment
13
Registered
2022-03-03
Start date
2020-01-13
Completion date
2021-09-30
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factor

Keywords

Coconut oil, Postprandial lipaemia, Platelet function, Gastric emptying, Appetite

Brief summary

Current dietary recommendations suggest that lowering intake of saturated fats or replacing it with unsaturated fats will decrease the risk of developing cardiovascular disease. Coconut oil has gained popularity in recent years but it contains 90% saturated fat, which has higher percentage of saturated fat than butter. To date, only limited studies have determined the acute effects of meals containing coconut oil on blood lipids, but findings are inconsistent. Therefore, further studies are needed to address this knowledge gap and compare the postprandial effects of test meals rich in coconut oil with other sources of saturated fatty acids such as butter and unsaturated fatty acids (vegetable oils). A cross-over, double-blind, randomised acute postprandial study will be conducted in 15 healthy men. Participants will be assigned to consume the test meals rich in saturated or unsaturated fatty acids in random order on 3 separate occasions, with 3-4 weeks between each study visit. Participants will be provided with breakfast (toast with jam and milkshake, 50g fat) and lunch (toast with jam and milkshake, 30g fat). The anthropometric, blood pressure, arterial stiffness, and breath samples will be taken for each study visit. Blood samples will be collected for the measurement of fasting lipids, glucose, insulin, inflammatory markers, whole blood culture as well as blood clotting. Breath samples are collected for the measurement of gastric emptying as well as assessment of satiety using questionnaires (100 mm visual analogue scale) completed throughout the day. The findings from this study will contribute to the evidence base on how consuming meals rich in coconut oil influence the level of blood lipids as well as other biomarkers for cardiovascular disease.

Interventions

DIETARY_SUPPLEMENTCoconut oil

50 g of coconut oil will be added to the test meal for breakfast and 30 g of coconut oil will be added to the test meal for lunch

DIETARY_SUPPLEMENTButter

50 g of butter will be added to the test meal for breakfast and 30 g of butter will be added to the test meal for lunch

DIETARY_SUPPLEMENTVegetable oil

50 g of vegetable oil will be added to the test meal for breakfast and 30 g of vegetable oil will be added to the test meal for lunch

Sponsors

University of Reading
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men * Aged between 30 to 70 years * Serum triacylglycerol \< 2.3 mmol/l * Body mass index between 19-32 kg/m2 * Total cholesterol \< 7.5 mmol/l

Exclusion criteria

* Females * Smokers * Medical history of myocardial infarction or stroke in the past 12 months * Diabetes (defined as fasting glucose \> 7.0 mmol/l) or other endocrine disorders * Kidney, liver, pancreas or gastrointestinal disorder * Hypertension (blood pressure \> 140/90 mmHg), cancer, medication for hyperlipidaemia (e.g. statins), hypertension or, inflammation * Anaemia (\<130 g/L haemoglobin) * Taking any dietary supplements known to influence lipids/gut microbiota (e.g. plant stanols, fish oil, phytochemicals, natural laxatives, probiotics and prebiotics) * Drinking in excess of 14 units of alcohol per week * Planning on a weight-reducing regime * Parallel participation in another dietary intervention study * Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention and metabolic study

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in postprandial triacylglycerolAcute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutesTriacylglycerol

Secondary

MeasureTime frameDescription
Fasting blood lipidsAcute study: taken at 0 (baseline)Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol
Change from baseline in postprandial non-esterified fatty acidsAcute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutesNon-esterified fatty acids
Change from baseline in postprandial insulinAcute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutesInsulin
Change from baseline in postprandial vascular stiffnessAcute study: taken at 0 (baseline), 150, 315, 465 minutesMeasured via pulse wave assessment using the Mobil-O-graph device
Change from baseline in postprandial blood pressureAcute study: taken at 0 (baseline), 180, 300, 480 minutesSystolic and diastolic blood pressure
Change from baseline in postprandial thrombin generationAcute study: taken at 0 (baseline), 180, 330, 480 minutesThrombin generation
Change from baseline in postprandial gastric emptyingAcute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutesAssessed using gas chromatography-mass spectrometry
Change from baseline in postprandial gut hormonesAcute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutesGhrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide-1
Change from baseline in postprandial endothelial activationAcute study: taken at 0 (baseline),180, 300 and 420 minutesE-selectin, P-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule-1
Change from baseline in postprandial cytokineAcute study: taken at 0 (baseline),180, 300 and 420 minutesInterleukin 6, interleukin 1 beta, interleukin 10, tumour necrosis factor alpha, C-C motif chemokine ligand 5, C-X-C motif chemokine ligand 5
WeightAcute study: taken at 0 (baseline)Body mass index will be calculated (kg/ height in m\^2)
Body compositionAcute study: taken at 0 (baseline)Fat mass, fat free mass, trunk fat, trunk fat mass, trunk fat free mass
Habitual diet assessmentPrior to the start of the study4-day food diary
Appetite ratingAcute study: taken at 30 minutes intervals after the test meals up to 8 hoursAssessed using 100 mm visual analogue questionnaire

Other

MeasureTime frameDescription
Genotyping for apolipoprotein EAcute study: taken at 0 (baseline)Single nucleotide polymorphisms related to the metabolism of dietary fats

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026